Table 1.
Baseline characteristics of the HS group population.
| Variables | HS (n = 96) |
|---|---|
| Gender, male/female, n (%) | 58 (60)/38 (40) |
| Age(year), Mean ± SD | 54 ± 9 |
| Etiology, HBV/HCV/alcohol or others, n (%) | 76 (79)/14 (15)/6 (6) |
| History of HCC treatment, yes/no, n (%) | 22 (23)/74 (77) |
| Preoperative anti-viral therapy, yes/no, n (%) | 56 (58)/40 (42) |
| Varices hemorrhage, yes/no, n (%) | 43 (45)/53 (55) |
| WBC (×109/L), Median (IQR) | 2.3 (1.8, 3.4) |
| HGB (g/L), Median (IQR) | 114.5 (88, 134.2) |
| PLT (×109/L), Median (IQR) | 47 (37, 65.2) |
| ALT (U/L), Median (IQR) | 28.5 (19, 41) |
| Tbil (umol/L), Median (IQR) | 21 (15.3, 28.7) |
| Albumin (g/L), Mean ± SD | 36.1 ± 5.4 |
| Child-Pugh score, n (%) | |
| 5 | 33 (34) |
| 6 | 36 (38) |
| 7 | 17 (18) |
| 8 | 8 (8) |
| 9 | 2 (2) |
| AFP (ng/mL), Median (IQR) | 23.7 (3.4, 234.2) |
| PTA (%), Mean ± SD | 72.5 ± 12.7 |
| Fibroscan (Kpa), Median (IQR) | 20.9 (14.5, 27.2) |
| Tumor diameter (mm), Median (IQR) | 24 (14, 39.2) |
| Tumor number, 1/2/3, n (%) | 82 (85)/10 (10)/4 (4) |
| Tumor stage, 1/2/3, n (%) | 48 (50)/39 (41)/9 (9) |
| Vascular invasion, yes/no, n (%) | 37 (39)/59 (61) |
| Pathological differentiation, high/middle/low, n (%) | 24 (25)/35 (36)/37 (39) |
| MVI, yes/no, n (%) | 23 (24)/73 (76) |
| Technique, resection/ablation, n (%) | 56 (58)/40 (42) |
| Hassab’s surgery, yes/no, n (%) | 54 (56)/42 (44) |
| Blood loss (ml), Median (IQR) | 350 (200, 700) |
| Surgical duration (h), Median (IQR) | 4.7 (3.6, 5.8) |
| Postoperative hospital stay (d), Median (IQR) | 14.6 (11.1, 19.6) |
| Postoperative mortality, n (%) | 5 (5) |
| Varices re-hemorrhage during follow-up, n (%) | 25 (26) |
| Tumor recurrence during follow-up, n (%) | 62 (65) |
| Overall RFS during follow-up (month), Median (IQR) | 22.3 (10.5, 48) |
| 1-year RFS, n (%) | 67 (70) |
| 2-year RFS, n (%) | 46 (48) |
| 3-year RFS, n (%) | 31 (36) |
| 5-year RFS, n (%) | 18 (22) |
| OS(month) during follow-up, Median (IQR) | 46 (22, 68.4) |
| 1-year OS, n (%) | 86 (90) |
| 3-year OS, n (%) | 56 (70) |
| 5-year OS, n (%) | 34 (49) |
Abbreviations: WBC, white blood cell count; HGB, hemoglobin; PLT, platelet count; ALT, alanine transaminase; Tbil, total bilirubin; PTA, Prothrombin activity; MVI, microvascular invasion; RFS, recurrence-free survival; OS, overall survival.